Azacitidine (5-Azacytidine)

Catalog No.S1782 Synonyms: 5-AzaC,Ladakamycin, AZA,5-Aza, CC-486

For research use only.

Azacitidine (5-Azacytidine, 5-AzaC, Ladakamycin, AZA, 5-Aza, CC-486) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases. Azacitidine induces mitochondrial apoptosis and autophagy.

Azacitidine (5-Azacytidine) Chemical Structure

CAS No. 320-67-2

Selleck's Azacitidine (5-Azacytidine) has been cited by 70 publications

Purity & Quality Control

Choose Selective DNA Methyltransferase Inhibitors

Biological Activity

Description Azacitidine (5-Azacytidine, 5-AzaC, Ladakamycin, AZA, 5-Aza, CC-486) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation by trapping DNA methyltransferases. Azacitidine induces mitochondrial apoptosis and autophagy.
Targets
DNA methyltransferase [1]
(Cell-free assay)
In vitro

Azacitidine is widely used to demonstrate the correlation between loss of methylation in specifc gene regions and activation of the associated genes. After incorporation into DNA, Azacitidine inhibits DNA methyltransferase noncompetitively, causing a block in cytosine methylation in newly replicated DNA but not in resting, nondividing cells. [1] Azacitidine induces differentiation of Friend Erythroleukemia Cell C3H10T1/2 with myotube formation. [2] Azacitidine can be activated to the nucleoside triphosphate and incorporate into both DNA and RNA, leading to inhibition of DNA, RNA and protein synthesis in normal eukaryotic cells and in cancer cell lines, which could finally leads to cell death. Azacitidine also inhibits the incorporation of purine metabolites into macromolecules. Azacitidine inhibits the L1210 cells growth with IC50 and of 0.019 μg/mL. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Raji  M3r0W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWPhWnJjOC5zLUWwJO69VQ>? MmD0NVIuPzJiaB?= NIXZTmNqdmirYnn0d{Bk\WyuIHfyc5d1cCCrbjDhJIRwe2ViZHXw[Y5l\W62IH3hco5meg>? NYTBbnZORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xN|MzPDZpPkK2NVM{OjR4PD;hQi=>
Jurkat  NVHQWZRsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M13KflAvOS13MDFOwG0> MnHRNVIuPzJiaB?= NUfxclNPcW6qaXLpeJMh[2WubDDndo94fGhiaX6gZUBld3OnIHTldIVv\GWwdDDtZY5v\XJ? MlHTQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{OyOFYoRjJ4MUOzNlQ3RC:jPh?=
CA46 MmLxSpVv[3Srb36gRZN{[Xl? M4OwT|IxyqEEtV2= MVe0PEBp MYLpcoNz\WG|ZYRCpHBVWExzwrDtVm5CKGW6cILld5Nqd25? M37xcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUOzNlQ3Lz5{NkGzN|I1PjxxYU6=
Raji  M2fDZmZ2dmO2aX;uJGF{e2G7 NYLobYpbOTYEoNM1US=> M{\hOlQ5KGh? MmrybY5kemWjc3XzxsBRXFCOMdMgcXJPSSCneIDy[ZN{cW:w Mli2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{OyOFYoRjJ4MUOzNlQ3RC:jPh?=
Jurkat  Moq2SpVv[3Srb36gRZN{[Xl? MVezMlXDqML3TR?= MkPLOFghcA>? MWfpcoNz\WG|ZYRCpHBVWExzwrDtVm5CKGW6cILld5Nqd25? MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|M{K0Okc,OjZzM{OyOFY9N2F-
MDA-MB-231 MYLGeY5kfGmxbjDBd5NigQ>? Mo\NNU8zNjVxNTFOwG0> NXXIbGFbPDhiaB?= MWXk[YNz\WG|ZYOgeIhmKFCWUF6xNkBmgHC{ZYPzbY9vKGG2IITo[UBkd26lZYLueJJifGmxbjDv[kA2yqEQvF2gOFjDqGh? M1vs[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEG3NlI6Lz5{NUixO|IzQTxxYU6=
MDA-MB-231 NInmRmdHfW6ldHnvckBCe3OjeR?= MmS2NU8zNjVxNTFOwG0> NHzHW|E1QCCq MnjWbY5kemWjc3XzJJRp\SCuZY\lcJMhd2ZiRT3jZYRp\XKrbjDtVm5CKGG2IITo[UBkd26lZYLueJJifGmxbjDv[kAzNjYEoN88UYZweiB2ONMgbC=> MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzN{KyPUc,OjV6MUeyNlk9N2F-
MDA-MB-231 NEPXRllHfW6ldHnvckBCe3OjeR?= Mn36NU8zNjVxNTFOwG0> MnvHNlQwPDhiaB?= MlXQbY5lfWOnczCgd4lodmmoaXPhcpQhWEGUUDDjcIVifmGpZTDh[pRmeiB2ODDo M{HONVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEG3NlI6Lz5{NUixO|IzQTxxYU6=
MCF-7 NFXp[HpHfW6ldHnvckBCe3OjeR?= MXexM|IvPS93IN88US=> NEPZOpEzPC92ODDo M4rrRolv[3KnYYPld{BRSVKSIHPs[YF3[WenwrC= MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPThzN{KyPUc,OjV6MUeyNlk9N2F-
MDA-MB-231  NX[4b4JVTnWwY4Tpc44hSXO|YYm= Mn[5NU8zNjVxNTFOwG0> MXWyOE81QCCq NYK0eGhRcW6lcnXhd4V{KHSqZTDlfJBz\XO|aX;uJI9nKG2rUl7BMVEzPCCjdDD0bIUh[2:wY3XycpRz[XSrb36gc4YhPSEQvF2= NH:xPHA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUixO|IzQSd-MkW4NVczOjl:L3G+
A498 MYfGeY5kfGmxbjDBd5NigQ>? NEG0cFYyOCEEtV2= Mn7mO|IhcA>? NUXjNGNjcW6mdXPld{B1cGViQVTBUXRUOThiZ3Xu[UBmgHC{ZYPzbY9v Ml3zQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3NkmwPFYoRjJ3NU[5NFg3RC:jPh?=
CaKI-2 M1PheWZ2dmO2aX;uJGF{e2G7 MXSxNEDDvU1? MlTMO|IhcA>? M3PSXIlv\HWlZYOgeIhmKEGGQV3UV|E5KGenbnWg[ZhxemW|c3nvci=> Mlv1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV3NkmwPFYoRjJ3NU[5NFg3RC:jPh?=
Ketr-3 MmfhSpVv[3Srb36gRZN{[Xl? MkPtNVAhyrWP M3TwPFczKGh? NVWyXHhwcW6mdXPld{B1cGViQVTBUXRUOThiZ3Xu[UBmgHC{ZYPzbY9v MVS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTV4OUC4Okc,OjV3NkmwPFY9N2F-
A253 NYT6[29RTnWwY4Tpc44hSXO|YYm= NF;mNZkyOCEEtV2= NVfZVGpwOC12IHS= NIP4XWxqdmO{ZXHz[ZMhfGinIH3SUmEh\XiycnXzd4lwdiCuZY\lcEBw\iC2aHWgUVNTyqCjZoTldkAzPCCq Mk\nQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2OEW1N|YoRjJ3NEi1OVM3RC:jPh?=
A253 MlTvSpVv[3Srb36gRZN{[Xl? MXixNEDDvU1? Ml7CO|IhcA>? M1fDVIlv[3KnYYPld{B1cGViZYjwdoV{e2mxbjDs[ZZmdCCxZjD0bIUhVTOUIHnuJIJwfGhibXXtZpJidmViYX7kJIN6fG:|b3zpZ{BxemWyYYLheIlwdnN? NW\nVnJORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0PFU2OzZpPkK1OFg2PTN4PD;hQi=>
A253 M2m0ZmZ2dmO2aX;uJGF{e2G7 MX[xNEDDvU1? MUewMVQh\A>? NUPhXIF6emWmdXPld{B1cGViNT3t[ZRpgWyleYTvd4lv\SClb370[Y51 NVL4eHdlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0PFU2OzZpPkK1OFg2PTN4PD;hQi=>
PC3 Ml3QSpVv[3Srb36gRZN{[Xl? M3G4T|AvOiEQvF5CpC=> MmLFOEBl Ml;ubY5kemWjc3XzJJRp\SCpZX7lJIV5eHKnc4Ppc44hd2ZiSVfGRnA4NCCVRmLQNUBidmRiU1zDOmEyPSClb33ibY5m\CC5aYToJGdUUzF{Nh?= NGnZcY09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS3O|M1OCd-MkW0O|c{PDB:L3G+
MCF7 M3rvZWZ2dmO2aX;uJGF{e2G7 Mmn5NE4{KM7:TdMg M2XRcFQh\A>? M4mwcolv[3KnYYPld{B1cGViZ3Xu[UBmgHC{ZYPzbY9vKG:oIFnHSmJRPyxiU1\SVFEh[W6mIGPMR|ZCOTViY3;tZolv\WRid3n0bEBIW0tzMk[= MlLyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2N{ezOFAoRjJ3NEe3N|QxRC:jPh?=
PC3 MkHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFzpXXExNjJizszNxsA> NHTNboo1KGR? M4\VSYRm[3KnYYPld{B1cGViY3XscEBoem:5dHigeI8hOjBwMzWgZ49u[mmwZXSge4l1cCCJU1uxNlY> NEPpVpU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS3O|M1OCd-MkW0O|c{PDB:L3G+
MCF7 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVywMlMh|ryPwrC= MkPROEBl MWPk[YNz\WG|ZYOgeIhmKGOnbHyg[5Jwf3SqIEK0MlgmKGOxbXLpcoVlKHerdHigS3NMOTJ4 NVjINXdiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|c{PDBpPkK1OFc4OzRyPD;hQi=>
BGC-823 MkT2SpVv[3Srb36gRZN{[Xl? MYe1xsDPxE1? NXXQeHdoPzJiaB?= MUfk[YNz\WG|ZYOgeIhmKFCUTD2zJJBzd3SnaX6gcIV3\Wxic3nncoln[2GwdHz5 Mn;1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2N{W3N|MoRjJ3NEe1O|M{RC:jPh?=
MKN28 MVnGeY5kfGmxbjDBd5NigQ>? NXPQbWlMPcLizszN NUnQRVRPPzJiaB?= M1r2dIRm[3KnYYPld{B1cGViUGLMMVMheHKxdHXpckBt\X[nbDDzbYdvcW[lYX70cJk> NX;iZmJxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|U4OzNpPkK1OFc2PzN|PD;hQi=>
SGC-7901 MoHXSpVv[3Srb36gRZN{[Xl? M3qzR|XDqM7:TR?= MX23NkBp NG\5[5Jl\WO{ZXHz[ZMhfGinIGDSUE0{KHC{b4TlbY4hdGW4ZXygd4lodmmoY3HueIx6 NILxfVE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUS3OVc{Oyd-MkW0O|U4OzN:L3G+
MKN45 MV7GeY5kfGmxbjDBd5NigQ>? NIHzSos2yqEQvF2= M3vKbVczKGh? NUDISmZz\GWlcnXhd4V{KHSqZTDQVmwuOyCycn;0[YlvKGyndnXsJJNq\26rZnPhcpRtgQ>? M4ry[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NEe1O|M{Lz5{NUS3OVc{OzxxYU6=
BGC-823 MUHGeY5kfGmxbjDBd5NigQ>? NYXsO3dGPcLizszN NYf1bZpmPzJiaB?= NFTpbpVl\WO{ZXHz[ZMhfGinIH3SUmEh\XiycnXzd4lwdiCxZjDQVmwuOyC|aXfubYZq[2GwdHz5 M2TWcFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NEe1O|M{Lz5{NUS3OVc{OzxxYU6=
MKN28 M3HaZ2Z2dmO2aX;uJGF{e2G7 M4TBO|XDqM7:TR?= NHPx[Ic4OiCq MnnP[IVkemWjc3XzJJRp\SCvUl7BJIV5eHKnc4Ppc44hd2ZiUGLMMVMhe2mpbnnmbYNidnSueR?= MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTR5NUezN{c,OjV2N{W3N|M9N2F-
SGC-7901 NUG1XWFSTnWwY4Tpc44hSXO|YYm= NIL3XFE2yqEQvF2= NGPGcnc4OiCq NV22dIZj\GWlcnXhd4V{KHSqZTDtVm5CKGW6cILld5Nqd25ib3[gVHJNNTNic3nncolncWOjboTsfS=> NVO1W41ZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW0O|U4OzNpPkK1OFc2PzN|PD;hQi=>
MKN45 MUnGeY5kfGmxbjDBd5NigQ>? M{jEdFXDqM7:TR?= NViwb2RsPzJiaB?= NXjxTHg4\GWlcnXhd4V{KHSqZTDtVm5CKGW6cILld5Nqd25ib3[gVHJNNTNic3nncolncWOjboTsfS=> MoLXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV2N{W3N|MoRjJ3NEe1O|M{RC:jPh?=
HREC MUDGeY5kfGmxbjDBd5NigQ>? MWq1M|ExyqEQvF2= MmnyOFghcA>? MUDpcoR2[2W|IGDFSGYhcW5iYTDkc5NmNWSncHXu[IVvfCCvYX7u[ZI> NH:zR|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO1Nlc1Pyd-MkWzOVI4PDd:L3G+
HRPE M1;IdmZ2dmO2aX;uJGF{e2G7 NED6N3I2NzFywrFOwG0> NGnWdmc1QCCq M2q3d4lv\HWlZYOgVGVFTiCrbjDhJIRwe2VvZHXw[Y5l\W62IH3hco5meg>? NVuwWJB5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWzOVI4PDdpPkK1N|UzPzR5PD;hQi=>
HREC NWDyd3JzTnWwY4Tpc44hSXO|YYm= MofEOU8yOMLizszN NEPqeXE1QCCq Mo\R[I94di2{ZXf1cIF1\XNib3[gWmVITixiSVPBUU0yKCiwb4SgdJJwfGWrbjDs[ZZmdCCrbjDIVnBGKGOnbHzzLUwhUUxvMd8yJIRwe2VvZHXw[Y5l\W62bIm= M2XVcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{WyO|Q4Lz5{NUO1Nlc1PzxxYU6=
HRPE MX;GeY5kfGmxbjDBd5NigQ>? NWfNc4lTPS9zMNMg{txO Mli2OFghcA>? MVTkc5dvNXKnZ4XsZZRmeyCxZjDWSWdHNCCLTD2x{tItKGGwZDDNUXAzKGSxc3Wt[IVx\W6mZX70cJk> NFTjRYs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO1Nlc1Pyd-MkWzOVI4PDd:L3G+
MSCs NXjH[IlRTnWwY4Tpc44hSXO|YYm= NH3VPWsyOCEQvF2= NYP2eHZSOjRiaB?= MnzxdJJwdW:2ZYOgeIhmKGOxbX3peI1mdnRib3[gUXNEeyC2bzDtfY9k[XKmaXHsJIRq\m[ncnXueIlifGmxbh?= MonPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV|NUGzPVUoRjJ3M{WxN|k2RC:jPh?=
HL-60 NHu2ZWxHfW6ldHnvckBCe3OjeR?= MYO1JO69VQ>? MUO3NkBp MnPmSG1UVw>? M{LUbJNq\26rZnnjZY51dHlidYDy[Yd2dGG2ZYOgXm5HOzh{IHX4dJJme3Orb36= M3P3fVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{G5NFQ6Lz5{NUOxPVA1QTxxYU6=
MV4-11 M2HzW2Z2dmO2aX;uJGF{e2G7 Ml7yOUDPxE1? NX3heVdtPzJiaB?= NUjDbndNTE2VTx?= M3X5NZNq\26rZnnjZY51dHlidYDy[Yd2dGG2ZYOgXm5HOzh{IHX4dJJme3Orb36= MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTNzOUC0PUc,OjV|MUmwOFk9N2F-
A2780 NYLoW3ZtTnWwY4Tpc44hSXO|YYm= NGn4ZpU2KML3TdMg MUC3JIQ> NI\Hbm9qdmO{ZXHz[ZMhTE6DIH3leIh6dGG2aX;uJIxmfmWu NYfyVnBRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWyPVk3QTRpPkK1Nlk6Pjl2PD;hQi=>
CP70 MlXzSpVv[3Srb36gRZN{[Xl? M4LBXFUhyrWPwrC= M4LCc|ch\A>? NYrkcWVDcW6lcnXhd4V{KESQQTDt[ZRpgWyjdHnvckBt\X[nbB?= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJ7OU[5OEc,OjV{OUm2PVQ9N2F-
A2780 NFP4[2JHfW6ldHnvckBCe3OjeR?= MnKwOUDDvU4EoB?= Mn7kO{Bl NWPmSm17f2Wja3Xud{B1cGVibHX2[Ywhd2ZibXX0bJlt[XSrb36= MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTJ7OU[5OEc,OjV{OUm2PVQ9N2F-
CP70 NFHJeVlHfW6ldHnvckBCe3OjeR?= NYToZYl6PSEEtV5CpC=> Mn3BO{Bl NVKybY5Sf2Wja3Xud{B1cGVibHX2[Ywhd2ZibXX0bJlt[XSrb36= M4HqV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3Mkm5Olk1Lz5{NUK5PVY6PDxxYU6=
OCM3 M3\iSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NULGTVlVOC53L{GvNkDPxE1? NX:2OFA{PyCm NWLxTIt5TE2VTx?= MYDpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uh\GWyZX7k[Y51KG2jbn7ldi=> MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
92.1 NV\ZPWNNT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFHaUXcxNjVxMT:yJO69VQ>? MmPHO{Bl NXe1d2VETE2VTx?= M{[1OIlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\SCmZYDlcoRmdnRibXHucoVz M{i4R|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
OCM1 NGPxc|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIDGN3MxNjVxMT:yJO69VQ>? M1HnXFch\A>? MVHEUXNQ Mn[5bY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmKGSncHXu[IVvfCCvYX7u[ZI> NVfpR3dxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
OMM1 NXn0bWZzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmrHNE42NzFxMjFOwG0> MVO3JIQ> MWPEUXNQ MXLpcohq[mm2czDj[YxtKGe{b4f0bEBqdiCjIHTvd4Uh\GWyZX7k[Y51KG2jbn7ldi=> NYjaZ2ZqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
Mel 285 Mlr4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFXPUGcxNjVxMT:yJO69VQ>? Ml6wO{Bl MVfEUXNQ M3zVZolvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\SCmZYDlcoRmdnRibXHucoVz NUjLOlhzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
Mel 290 M{D5[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXqwMlUwOS9{IN88US=> MorrO{Bl M3uwUmROW09? Mn3tbY5pcWKrdIOgZ4VtdCCpcn;3eIghcW5iYTDkc5NmKGSncHXu[IVvfCCvYX7u[ZI> MmLKQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OCM3 NVPkTnlxTnWwY4Tpc44hSXO|YYm= NGrLUIYxNjVxMTFOwG0> NHXqbJE1QCCq M{D4U2ROW09? NEPiNZZl\WO{ZXHz[ZMh[2yxbn;n[Y5q[2m2eTDkc5NmNWSncHXu[IVvfGy7 NIPM[HU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
92.1 M2C3W2Z2dmO2aX;uJGF{e2G7 MXqwMlUwOSEQvF2= MkLkOFghcA>? MYrEUXNQ NWXRUYZ2\GWlcnXhd4V{KGOub37v[4VvcWOrdImg[I9{\S2mZYDlcoRmdnSueR?= Ml2yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OCM1 MlfJSpVv[3Srb36gRZN{[Xl? M3j5OVAvPS9zIN88US=> M{W0fFQ5KGh? MoLFSG1UVw>? MYfk[YNz\WG|ZYOgZ4xwdm:pZX7pZ4l1gSCmb4PlMYRmeGWwZHXueIx6 MmfzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNE[5PFEoRjJ3MUS2PVgyRC:jPh?=
OMM1 M4n0TmZ2dmO2aX;uJGF{e2G7 NIrIeHcxNjVxMTFOwG0> M3LEXVQ5KGh? MV3EUXNQ MW\k[YNz\WG|ZYOgZ4xwdm:pZX7pZ4l1gSCmb4PlMYRmeGWwZHXueIx6 MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
Mel 285 NULrU4hETnWwY4Tpc44hSXO|YYm= NH3ScIkxNjVxMTFOwG0> NVXCc5dPPDhiaB?= MYDEUXNQ NIXuZZpl\WO{ZXHz[ZMh[2yxbn;n[Y5q[2m2eTDkc5NmNWSncHXu[IVvfGy7 NHTqZ489[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
Mel 290 MWDGeY5kfGmxbjDBd5NigQ>? M3jPV|AvPS9zIN88US=> M2KydlQ5KGh? MkSxSG1UVw>? NHzFO2Nl\WO{ZXHz[ZMh[2yxbn;n[Y5q[2m2eTDkc5NmNWSncHXu[IVvfGy7 M3vyUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
OCM3 M3K4WGZ2dmO2aX;uJGF{e2G7 NWHmW3ExOC53L{Gg{txO M3K2dFQ5KGh? NFfifphFVVOR NWK2N|BF\GWlcnXhd4V{KGmwdnHzbY9vKGSxc3Wg[IVx\W6mZX70cJnDqA>? M4DBOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
Mel 290 M4fTSGZ2dmO2aX;uJGF{e2G7 NF7nZ5ExNjVxMTFOwG0> M3jMbFQ5KGh? MknjSG1UVw>? M3e4WoRm[3KnYYPld{Bqdn[jc3nvckBld3OnIHTldIVv\GWwdHz5xsA> MXG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
OMM1 MYLGeY5kfGmxbjDBd5NigQ>? Mn;INE42NzFizszN NF3LTYM1QCCq M1qx[2ROW09? NEjlbZJl\WO{ZXHz[ZMhcW64YYPpc44h\G:|ZTDk[ZBmdmSnboTsfeKh NELURmc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
OCM1 M1XMRmNmdGxiVnnhZoltcXS7IFHzd4F6 MljzNE42NzFizszN NGi5d|E2KGR? NXXmdHk6TE2VTx?= NEPUS4pl\WO{ZXHz[ZMhemGmaXH0bY9vNWmwZIXj[YQh[2WubDD2bYFjcWyrdImgbY5pcWKrdHnvci=> NHr4T4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG0Olk5OSd-MkWxOFY6QDF:L3G+
92.1 MorBR4VtdCCYaXHibYxqfHliQYPzZZk> NX:xcmR5OC53L{Gg{txO MWq1JIQ> MWDEUXNQ MV7k[YNz\WG|ZYOgdoFlcWG2aX;uMYlv\HWlZXSgZ4VtdCC4aXHibYxqfHliaX7obYJqfGmxbh?= NXuxN|FORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOFY6QDFpPkK1NVQ3QThzPD;hQi=>
OCM1 NYK1OYJ{TnWwY4Tpc44hSXO|YYm= M3zYeFAvPS9zIN88US=> NGn6XVA1QCCq NEPXNZZFVVOR NUDXeHU2[2G3c3XzJIdtd2KjbDDEUmEhcHmyb33leIh6dGG2aX;uJIF1KExvMTDy[ZBm[XRibH;jbS=> MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
OCM3 NVHlOHBlTnWwY4Tpc44hSXO|YYm= M33iRVAvPS9zIN88US=> M3HCXlQ5KGh? MU\EUXNQ MoWzZ4F2e2W|IHfsc4JidCCGTlGgbJlxd22ndHj5cIF1cW:wIHH0JGwuOSC{ZYDlZZQhdG:laR?= M1:1TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUS2PVgyLz5{NUG0Olk5OTxxYU6=
92.1 MlzmSpVv[3Srb36gRZN{[Xl? MYKwMlUwOSEQvF2= NWe5O3Z6PDhiaB?= MX\EUXNQ NIe2fWtk[XW|ZYOg[4xw[mGuIFTORUBpgXCxbXX0bJlt[XSrb36gZZQhVC1zIILldIVifCCub3Pp MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF2Nkm4NUc,OjVzNE[5PFE9N2F-
IMR32 NVfTTJhWTnWwY4Tpc44hSXO|YYm= M1nsfVMh|ryP M4PZPFczKGh? MYXEUXNQ MYjpcoR2[2W|wrDwNVkuUU6NNHVCpIV5eHKnc4Ppc47DqHOrZ37p[olk[W62bIm= MoTjQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzMES4OVAoRjJ3MUC0PFUxRC:jPh?=
IMR5-75 Mnj4SpVv[3Srb36gRZN{[Xl? NEj4UpM{KM7:TR?= NVT0c5YyPzJiaB?= MljQSG1UVw>? NWPwZXJ{cW6mdXPld:KheDF7LVnOT|RlyqCneIDy[ZN{cW:wwrDzbYdvcW[rY3HueIx6 M4XWN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUC0PFUxLz5{NUGwOFg2ODxxYU6=
Be(2)-C Ml7iSpVv[3Srb36gRZN{[Xl? M2LUV|Mh|ryP NEjCNZk4OiCq MWLEUXNQ MV7pcoR2[2W|wrDwNVkuUU6NNHVCpIV5eHKnc4Ppc47DqHOrZ37p[olk[W62bIm= MkLJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzMES4OVAoRjJ3MUC0PFUxRC:jPh?=
Bxpc-3 MknuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3rWZVUwOTBizszN MVuyOE81QC95MjDo MlHZbY5pcWKrdIOgeIhmKHC{b3zp[oVz[XSrb36gc4YhSniyYz2zJINmdGy|IHnuJJRqdWVvIHHu[EBkd26lZX70doF1cW:wLXTldIVv\GWwdDDtZY5v\XK| NF\oW2E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUC2NVc{OSd-MkWwOlE4OzF:L3G+
Bxpc-3 Mnq2RZBweHSxc3nzJGF{e2G7 Mm[5OU8yOCEQvF2= MnXrNlQwPDhxN{KgbC=> MofmbY5lfWOnczDhdI9xfG:|aYOgbY4hfGmvZT2gZY5lKGOxbnPldo51emG2aX;uJI1idm6ncoO= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTB4MUezNUc,OjVyNkG3N|E9N2F-
Bxpc-3 MnixSpVv[3Srb36gRZN{[Xl? MYO1M|ExKM7:TR?= M2fOWVI1NzR6L{eyJIg> MV;k[YNz\WG|ZYOg{tIu[2G2ZX7pckBmgHC{ZYPzbY9vKGGodHXyJFI1KGh? NYH5R5FrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwOlE4OzFpPkK1NFYyPzNzPD;hQi=>
Bxpc-3 NYnCTVhyTnWwY4Tpc44hSXO|YYm= M2HzZlUwOTBizszN NUW5UYpYOjRxNEivO|IhcA>? MXnk[YNz\WG|ZYOgZ5lkdGmwREGg[ZhxemW|c3nvckBifCC2aHWgZ49v[2W{boTyZZRqd25ib3[gNVAh|ryP M{fRSVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3ME[xO|MyLz5{NUC2NVc{OTxxYU6=
Bxpc-3 Mo\sSpVv[3Srb36gRZN{[Xl? MkHXOU8yOCEQvF2= MkCwNlQwPDhxN{KgbC=> NYTRSYhS\G:5bj3y[Yd2dGG2ZWOgZ{1ugWNibWLORUBmgHC{ZYPzbY9vKGmwIITpcYUuKGGwZDDjc45k\W62cnH0bY9vNWSncHXu[IVvfCCvYX7u[ZJ{ NGHERZQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUC2NVc{OSd-MkWwOlE4OzF:L3G+
HL-60 NI\XbXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV:xMlAh|ryP MVS0PEBp MkjFd4lodmmoaXPhcpRtgSCrbnjpZol1eyCKTD22NEBk\WyuIHfyc5d1cMLi NVHrfZpvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwOVEyOTlpPkK1NFUyOTF7PD;hQi=>
HL-60 NF22XmVHfW6ldHnvckBCe3OjeR?= M1nnclEvOCEQvF2= Mn35OFghcA>? MnKwbY5kemWjc3XzJJAzOVeDRkGvR2lROcLiYX7kJINie3Cjc3WtN{BmgHC{ZYPzbY9vyqB? NGHmfG09[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUC1NVEyQSd-MkWwOVEyOTl:L3G+
HL-60 MWnGeY5kfGmxbjDBd5NigQ>? NEHofZUyNjBizszN NHjRS2M1QCCq M4Ty[IRm[3KnYYPld{BD[2xveFyg[ZhxemW|c3nvcuKhe2mpbnnmbYNidnSueR?= NIfjNmw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUC1NVEyQSd-MkWwOVEyOTl:L3G+
HuTu-80  NF;aRm1HfW6ldHnvckBCe3OjeR?= M3WyWlEwPS9zMDFOwG0> M1jjV|Q5Nzd{IHi= Ml:3bY5kemWjc3XzJJRp\SCneIDy[ZN{cW:wIH;mJIh2dWGwIF7QR|FNOSCvUl7BJIlvKGFiZH;z[U1l\XCnbnTlcpQhdWGwbnXy NXvYPWRkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFQxPjJpPkK0PVA1ODZ{PD;hQi=>
Caco2  MmXDSpVv[3Srb36gRZN{[Xl? MnTJNVAh|ryP NUDFeJFCPDhiaB?= NG\SWJdqdmO{ZXHz[ZMhVlCFMVyxJIV5eHKnc4Ppc44> Mn:1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MESwOlIoRjJ2OUC0NFYzRC:jPh?=
HepG2  MWnGeY5kfGmxbjDBd5NigQ>? Mkn3NE0zPSEQvF2= M4rDfFI1KGh? MVPk[YNz\WG|ZYOgd5VjfGmuaYPpck9s\XirbjD0fZBmKDliKGDDV2s6MSCycn;0[YlvKGyndnXsd{Bld3OnIHTldIVv\GWwdHz5 NGfaZm89[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi1OVY1Pid-MkS4OVU3PDZ:L3G+
HepG2  M3HZcWZ2dmO2aX;uJGF{e2G7 M3TKU|AuOjVizszN NEPGR3IzPCCq MlTKbY5kemWjc3XzJIxwfyCmZX7zbZR6KGyrcH;wdo91\WmwIILlZ4VxfG:{IDjMSGxTMSCpZX7lJIV5eHKnc4Ppc47DqA>? M1rSUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEW1OlQ3Lz5{NEi1OVY1PjxxYU6=
HepG2  NXjGRVJ6TnWwY4Tpc44hSXO|YYm= NYSyZ3Z3OTBizsztxsA> Mmi2NE0zPCCq MVTk[YNz\WG|ZYRCpHBEW0t7wrDhcoTDqEiPR1PSxsBmgHC{ZYPzbY9vKGGwZDDpcoNz\WG|ZYOgUGRNWiCneIDy[ZN{cW:wIHHmeIVzKDZiaB?= NXHLRmlORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HepG2  NWTTeYxvTnWwY4Tpc44hSXO|YYm= NYLQUJVOOTBizszt M1\wWVI1KGh? M1fxSpBzd22xdHXzJIN6fG:|b3zpZ{Bv\XW2cnHsJIxqeGmmIHHjZ5VufWyjdHnvckBqdmSncHXu[IVvfGy7IH;mJIV5d2enbn;1d{BtcXCxcILveIVqdnN? Mnf2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6NUW2OFYoRjJ2OEW1OlQ3RC:jPh?=
HepG2  NE\LfIlHfW6ldHnvckBCe3OjeR?= M{[zZlExKM7:bR?= MlLoNlQhcA>? MoO2dJJmfmWwdIOgV3JGSlBicILvZ4V{e2mwZx?= NUPFbGc2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4OVU3PDZpPkK0PFU2PjR4PD;hQi=>
HC45  MlfMSpVv[3Srb36gRZN{[Xl? NIrTPIw2yrWPwrC= M4PpVlQh\A>? M{HKbpJm\HWlZYOgeIhmKG2ndHj5cIF1cW:wIHzleoVteyCxZjDXTWYyNCCSMU[sJGNZS0xzNDygUmtZOuLCk{OsJGNFUDFuIFzBUWEyNCCjbnSgR3RPVkJz M4XCT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{[yPFA6Lz5{NEe2NlgxQTxxYU6=
CNDT2  NEfkXZNHfW6ldHnvckBCe3OjeR?= MYG1xtVOyqB? NFHGVmQ1KGR? MVfy[YR2[2W|IITo[UBu\XSqeXzheIlwdiCuZY\lcJMhd2ZiV1nGNUwhWDF4LDDDXGNNOTRuIF7LXFLjiJN|LDDDSGgyNCCOQV3BNUwh[W6mIFPUUm5DOQ>? NXL0T286RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OlI5ODlpPkK0O|YzQDB7PD;hQi=>
CNDT2  MX\GeY5kfGmxbjDBd5NigQ>? NGXNTos2yrWPwrC= NHzoeJY1KGR? M3H6eIlv[3KnYYPld{Bo\W6nIHX4dJJme3Orb36gc4bDqFeLRkGsJHAyPixiQ1TINUzDqEyDTVGxMOKh[W6mwrDDWG5PSjF? MlT2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NkK4NFkoRjJ2N{[yPFA6RC:jPh?=
T-cells NYm2WYF3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NITHWFM2NzJyIN88US=> M1fmWVAuPDhiaB?= M2\EdYlvcGmkaYTzJINmdGxiZ4Lve5RpKGmwIHGg[I9{\SCmZYDlcoRmdnRibXHucoVz MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd3N{K4N{c,OjR5NUeyPFM9N2F-
CD3+ T-cells MYHGeY5kfGmxbjDBd5NigQ>? NIj3Z5U2NzJyIN88US=> NIrKd4o1QCCq MVv1dJJm\3WuYYTld{BxOTViZYjwdoV{e2mxbh?= M2LFUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD4+ T-cells Mn7FSpVv[3Srb36gRZN{[Xl? NXTjTIJEPS9{MDFOwG0> NYrTOYVmPDhiaB?= MX71dJJm\3WuYYTld{BxOTViZYjwdoV{e2mxbh?= NHH2XIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe1O|I5Oyd-MkS3OVczQDN:L3G+
CD8+ T-cells MYXGeY5kfGmxbjDBd5NigQ>? NVTFW4JYPS9{MDFOwG0> NFTlZ4c1QCCq NHvqVGd2eHKnZ4XsZZRmeyCyMUWg[ZhxemW|c3nvci=> M3jPdlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD3+ T-cells NHy5W2RHfW6ldHnvckBCe3OjeR?= NXn3cGpiPS9{MDFOwG0> MlzqOFghcA>? NYTNXlZ7fXC{ZXf1cIF1\XNidHjlJIV5eHKnc4Ppc44hd2ZiRl;YVFM> MlPHQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells MoPCSpVv[3Srb36gRZN{[Xl? Mk[xOU8zOCEQvF2= MoTVOFghcA>? M4i4T5VxemWpdXzheIV{KHSqZTDlfJBz\XO|aX;uJI9nKE[RWGCz Mnf1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells M4HQ[WZ2dmO2aX;uJGF{e2G7 NWO2UW5lPS9{MDFOwG0> MXu0PEBp MV7y[YR2[2W|IGTCSXQyyqCvUl7BJIV5eHKnc4Ppc44> M1Hq[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD4+ T-cells NX\2dFVGTnWwY4Tpc44hSXO|YYm= NYPMNI4yPS9{MDFOwG0> MoixOFghcA>? NF;scVd2eHKnZ4XsZZRmeyC2aHWg[ZhxemW|c3nvckBw\sLiUl;S{tN1yqB? MmPFQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
CD4+ T-cells M1Xyc2Z2dmO2aX;uJGF{e2G7 MnGzOU8zOCEQvF2= NEC0Wmc1QCCq MlTvbY5pcWKrdIOgcYVud3K7IGStZ4VtdHN? MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd3N{K4N{c,OjR5NUeyPFM9N2F-
CD8+ T-cells NXO3cpF1TnWwY4Tpc44hSXO|YYm= MXO1M|IxKM7:TR?= NXHyNW5PPDhiaB?= MkfKbY5pcWKrdIOgcYVud3K7IGStZ4VtdHN? M4W1bVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{W3Nlg{Lz5{NEe1O|I5OzxxYU6=
CD3+ T-cells NXrN[WtUTnWwY4Tpc44hSXO|YYm= NX70OHNHPSEQvF2= NWSwT3pyPDhiaB?= NH7Ndolz\WS3Y3XzJIxwdmdvdHXycUBu\W2xcomgZ4VtdCCyaHXuc5R6eGV? MmTUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NUeyPFMoRjJ2N{W3Nlg{RC:jPh?=
U937 NYPBPFY1SXCxcITvd4l{KEG|c3H5 M2H2NFExKM7:TR?= MkHXO|IhcA>? NW\PPGRpcW6mdXPld{BieG:ydH;zbZMhe2mpbnnmbYNidnSueR?= MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ6MEi2OUc,OjR4OEC4OlU9N2F-
HL-60 NHHUVlRCeG:ydH;zbZMhSXO|YYm= MoP5NVAh|ryP MXy3NkBp NHWyeIJqdmS3Y3XzJIFxd3C2b4Ppd{B{cWewaX\pZ4FvfGy7 MlWzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4OEC4OlUoRjJ2NkiwPFY2RC:jPh?=
MCF7 NEjFV2pHfW6ldHnvckBCe3OjeR?= MljaOUDPxE1? MnP2OFghcMLi NGCxNHFlcXOybHH5d{B{\WynY4TpeoUhfG:6aXPpeJkhfG:5YYLkJJN2e3CnbnTl[EBOS0ZvNzDj[Yxtew>? NIfC[4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zN|M2OCd-MkS2N|M{PTB:L3G+
MCF7 MnTYSpVv[3Srb36gRZN{[Xl? NHHvUZYyOCEQvF2= NVzCOG1jOjRiaNMg MXvpcoR2[2W|IITo[UBkdGWjdnHn[UBw\iClYYPwZZNmKDdiYX7kJHBCWlEEoB?= MnjSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
MCF7 MVfGeY5kfGmxbjDBd5NigQ>? NUnqfZNxOOLCk{CuOUDPxE4EoB?= M3T5R|ch\A>? NI\tV3ZqdmirYnn0d{B1cGViZ4Lve5RpKE2FRj23JJR2dW:{c4Do[ZJmeyCrbjDzeZNx\W6|aX;uJIN2dHS3cnXzxsA> Ml7CQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
MCF7 NVnXdHV{TnWwY4Tpc44hSXO|YYm= M2XUflAvPSEQvF5CpC=> M3zaVFE1KGR? NH3FN3Nz\WS3Y3XzJJRp\SC|aYrlJI9nKE2FRj23JINwdG:waXXzJIVu[mWmZHXkJIlvKHOxZoSgZYdieg>? MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ|M{O1NEc,OjR4M{OzOVA9N2F-
MCF7 MYrGeY5kfGmxbjDBd5NigQ>? M{nXdFAvODYkgKOyNEDPxE1? MoKxNUBl NVPv[G92emWmdXPld{B1cGViY3zvcoFtKHO3co\peoFtKG:oIF3DSk04KGOnbHzzJIlvKG2xbn;sZZlmeiCldXz0eZJmew>? MkfSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
T47D  NVmwPXV[TnWwY4Tpc44hSXO|YYm= MkPYNE42KM7:TR?= NHjHNm41KGR? NHewT21qdmirYnn0d{B1fW2xcoPwbIVz\SCob4LtZZRqd25? MlPGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{OzOVAoRjJ2NkOzN|UxRC:jPh?=
MCF7 M2DiVmZ2dmO2aX;uJGF{e2G7 MUGwMlXjiJNzMDFOwG0> M4XkelQ5KGkEoB?= MYPpcohq[mm2czD0bIUh\2GyIHPsc5N2emViaX6geIhmKHexdX7kJIhm[WyrbnegZZN{[Xl? MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDZ|M{O1NEc,OjR4M{OzOVA9N2F-
MCF7 M1jBWGZ2dmO2aX;uJGF{e2G7 NHn0bHcxNzFyIN88US=> MX:yOEBp Mn24bY5pcWKrdIOgeIhmKGGldHn2bZR6KG:oIF3NVFk> NVLNemdZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS2N|M{PTBpPkK0OlM{OzVyPD;hQi=>
MDA-MB-231  MYrGeY5kfGmxbjDBd5NigQ>? MX:wMlXjiJNzMDFOwG0> MV[zOkBp M3O3U4lvcGmkaYTzJJRp\SCvaXfyZZRqd25? NFy0OmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zN|M2OCd-MkS2N|M{PTB:L3G+
SKM1-S MV7BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MVS0PEBpenN? MlHMRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCVS12xMXMh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IGjUWEBie3OjeTygTWM2OCB;IECuOUDPxE1w M1HWfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6MEm0PVM5Lz5{OEC5OFk{QDxxYU6=
SKM1-S MYTBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? MkPhOFghcHK| NWK5RmhMSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTT20yNVNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JGRCWElvc4ThbY5qdmdvYnHz[YQh\myxdzDjfZRwdWW2cnnjJI1mfGixZDygSWM2OCB;IECuOVEh|ryPLh?= NUDyfVFCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkiwPVQ6OzhpPkK4NFk1QTN6PD;hQi=>
A427 NETpN|RCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= NWK3Z2hiQTZiaILz NFXKOm1CdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG0Nlch[2WubIOgZYZ1\XJiOU[gbJJ{KGK7IHPyfZN1[WxidnnvcIV1KGG|c3H5MEBKSzVyIE2gNE43OyEQvF2u M1jWT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NEO0NVY{Lz5zOESzOFE3OzxxYU6=
KYSE70 MWHBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NWLafY1{QTZiaILz M{fJ[GFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iS2nTSVcxKGOnbHzzJIFnfGW{IEm2JIhzeyCkeTDjdpl{fGGuII\pc4xmfCCjc4PhfUwhUUN3MDC9JFEvPTlizszNMi=> NIHpZlc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOESzOFE3Oyd-MUi0N|QyPjN:L3G+
5637 Ml;nRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MoDPPVYhcHK| MULBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKDV4M{egZ4VtdHNiYX\0[ZIhQTZiaILzJIJ6KGO{eYP0ZYwhfmmxbHX0JIF{e2G7LDDJR|UxKD1iMT63N{DPxE1w NWPLV41qRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0N|QyPjNpPkG4OFM1OTZ|PD;hQi=>
HT-29 M2f3SGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NWezSIpVQTZiaILz MVzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiWLUK5JINmdGy|IHHmeIVzKDl4IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSB|Lkig{txONg>? M{nCPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5N{i0OFkoRjJ5N{i0OFk9N2F-
P388 M4jQSWFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MnnWOFghcHK| M3nRVWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViUEO4PEBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDJR|UxKD1iNTFOwG0v MnzCQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd5OES0PUc,Ojd5OES0PVww[T5?
MCF7 NUDiXIp4SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MWe5OkBpenN? M4LMb2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB7NjDodpMh[nliY4L5d5RidCC4aX;s[ZQh[XO|YYmsJGlEPTBiPTC2Mlc5KM7:TT6= Mo\OQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh2M{SxOlMoRjF6NEO0NVY{RC:jPh?=
U373-MAGI MknLRY51cX[rcnHsJIF{e2G7 MnPENlUhfG9iNECwJJVO MWOyJJRwKDd{IHjydy=> NI\nWnVCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBXW1ZvRzDwd4V2\G:2eYDl[EBJUVZvMTDOUFQuOyCrbn\lZ5Rm\CCrbjDoeY1idiCXM{ezMW1CT0liY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJIdi\yCuZY\lcEBifCB{NTD0c{A1ODBidV2gZYZ1\XJiMjD0c{A4OiCqcoOgZpkheVCFUjDt[ZRpd2R? MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzFzN{K2NEc,OjdzMUeyOlA9N2F-
U373-MAGI NV;qUVRCSW62aY\pdoFtKGG|c3H5 M{nmPVI2KHSxIESwNEB2VQ>? M1;Ce|IhfG9iN{KgbJJ{ M1XSTWFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JHZUXi2JIIDz[ZVld3S7cHXkJGhKXi1zIF7MOE0{KGmwZnXjeIVlKGmwIHj1cYFvKFV|N{OtUWFIUSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gWVUu\2GpIHzleoVtKGG2IEK1JJRwKDRyMDD1UUBi\nSncjCyJJRwKDd{IHjyd{BjgSCzUFPSJI1mfGixZB?= MoPrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjdzMUeyOlAoRjJ5MUG3NlYxRC:jPh?=
L1210 MUHDfZRwfG:6aXPpeJkh[XO|YYm= MmHWR5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgUFEzOTBiY3XscJMh[XO|ZYPz[YQh[XNiY3Xzd4F1cW:wIH;mJIdzd3e2aB?= MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek83QTB{Nje+OlkxOjZ:L3G+
TC32 MnfGdWhVWyCjc4PhfS=> M4jENJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCWQ{OyJINmdGy| Mk\xQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
A673 M{\Re5FJXFNiYYPzZZk> MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSTZ5MzDj[Yxtew>? NUfRdoxCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 MY\xTHRUKGG|c3H5 NHfYRYhyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStN|ch[2WubIO= MWG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD M3r6SZFJXFNiYYPzZZk> NX\tTI5TeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGLEJINmdGy| M4PKVlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
BT-12 NXHNcm1[eUiWUzDhd5NigQ>? NELJd|FyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB1643 NF\Hdo9yUFSVIHHzd4F6 MkLOdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucx?= NIDYXlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
OHS-50 MYjxTHRUKGG|c3H5 Mln4dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE:KUz21NEBk\Wyucx?= MkPkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC M1X3N5FJXFNiYYPzZZk> M1zod5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzz MkW0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SKM1-S MXLBdI9xfG:|aYOgZZN{[Xl? Mom0NUB2VQ>? MmjlTY5lfWO2aX;uJI9nKGGyb4D0c5NqeyCrbjDoeY1idiCVS12xMXMh[2WubIOgZZN{\XO|ZXSgZZMh[2G|cHHz[UA{KGOuZXH2ZYdmKGG2IEGgeW0h[nliV3XzeIVzdiCkbH;0JI1mfGixZB?= MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDB7NEmzPEc,OjhyOUS5N|g9N2F-
MCF7 NHXDUYxHfW6ldHnvckBie3OjeR?= MnWyNVUhfU1? NInodJI4OiCqcoO= NFT1UldKdmirYnn0bY9vKG:oIGXIVmYyKGmwIHj1cYFvKE2FRkegZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hdWW2aInsZZRqd25iYYSgVmFTKGKndHGg[ZhwdiCjdDCxOUB2VSCjZoTldkA4OiCqcoOgZpkhdWW2aInsZZRqd25ic4DlZ4lncWNvUFPSJI1mfGixZB?= MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzB2OUW3O{c,OjdyNEm1O|c9N2F-
Assay
Methods Test Index PMID
Western blot DNMT1 ; c-PARP / p-H2AX / H2AX 28210112
Immunofluorescence HMGB1 29097772
Growth inhibition assay Cell viability 28210112
In vivo Azacitidine inhibits polynucleotide synthesis in leukemic BDF1 mice. [3] Azacitidine (3 mg/kg, i.p.) increases the mean survival time in leukemic BDF1 mice inoculated with Ll210 ascites tumor cells. Azacitidine markedly suppresses all enzymes activity in the polyamine-biosynthetic pathway, including ornithine decarboxylase activity. putrescine-dependent S-adenosyl-L-methionine decarboxylase activity, and spermidine-dependent S-adenosyl-L-methionine decarboxylase activity. Azacitidine also inhibits the accumulations of polyamines in leukemic mice. [4]

Protocol (from reference)

Cell Research:[3]
  • Cell lines: Leukemia L1210 cell
  • Concentrations: 0.15 μg/mL
  • Incubation Time: 3 days
  • Method: 5 mL of L1210 cells (5 × 103 cells/mL) are incubated with Azacitidine at 37 ℃ for 3 days. Cell number is determined twice a day for 3 days by means of a Model A Coulter counter.
Animal Research:[4]
  • Animal Models: BDF1 mice bearing lymphoid leukemia L1210
  • Dosages: 3 mg/kg
  • Administration: Daily i.p. injection

Solubility (25°C)

In vitro

DMSO 48 mg/mL warmed
(196.56 mM)
Water Insoluble
Ethanol Insoluble

In vivo

Add solvents to the product individually and in order
(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+ddH2O
For best results, use promptly after mixing.

10mg/mL

Chemical Information

Molecular Weight 244.2
Formula

C8H12N4O5

CAS No. 320-67-2
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05155709 Not yet recruiting Drug: siremadlin|Drug: venetoclax|Drug: azacitidine Acute Myeloid Leukemia Novartis Pharmaceuticals|Novartis February 24 2022 Phase 1|Phase 2
NCT05140811 Not yet recruiting Drug: IMM01|Drug: Azacitidine Acute Myeloid Leukemia|Myelodysplastic Syndromes ImmuneOnco Biopharmaceuticals (Shanghai) Co. Ltd|Institute of Hematology & Blood Diseases Hospital January 1 2022 Phase 1|Phase 2
NCT05141682 Not yet recruiting Drug: Oral Azacitidine Recurrent T-Cell Large Granular Lymphocyte Leukemia|Refractory T-Cell Large Granular Lymphocyte Leukemia|T-Cell Large Granular Lymphocyte Leukemia Jonathan Brammer|Bristol-Myers Squibb|Ohio State University Comprehensive Cancer Center December 1 2021 Phase 1|Phase 2
NCT05074355 Not yet recruiting Drug: Azacitidine|Drug: Venetoclax Myeloproliferative Neoplasm|BCR-ABL Negative University Health Network Toronto December 6 2021 Phase 2
NCT04891068 Recruiting Drug: Azacitidine Breast Cancer Female|Breast Cancer Invasive University of Illinois at Chicago December 31 2021 Phase 2

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Frequently Asked Questions

Question 1:
Is the vehicle (30% Propylene glycol, 5% Tween 80, 65% D5W) for Azacitidine (Catalog No.S1782) safe for subcutaneous dosing?

Answer:
S1782 in 30% Propylene glycol+5% Tween 80+65% D5W at 30mg/ml is a suspension. If you are going to administrate this compound for oral gavage, it is fine. But if you administrate the drug via injection, you need a clear solution and S1782 can be dissolved in 5% DMSO+30% PEG 300+ddH2O at 10mg/ml clearly.

Tags: buy Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) supplier | purchase Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) cost | Azacitidine (5-Azacytidine) manufacturer | order Azacitidine (5-Azacytidine) | Azacitidine (5-Azacytidine) distributor